FABP1 and metabolic dysfunction-associated steatotic liver disease: On the basis of these reports, we think that endogenous FABP1 from hepatocytes may play a significant pathophysiological role in liver disease, and that further studies are required to ascertain the role of FABP1 in patients presenting with NAFLD.